Home › NDC Lookup › RxCUI directory › RxCUI 2637767

Beremagene geperpavec-svdt 5000000000 UNT/ML Topical Suspension [Vyjuvek] — RxCUI 2637767

RxNorm drug concept · Semantic branded drug
RxCUI 2637767 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2637767
Official nameBeremagene geperpavec-svdt 5000000000 UNT/ML Topical Suspension [Vyjuvek]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVyjuvek 5,000,000,000 PFU/ML Topical Suspension; Vyjuvek 5,000,000,000 UNT/ML Topical Suspension
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)3,025 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Beremagene geperpavec-svdt 5000000000 UNT/ML Top... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Beremagene geperpavec-svdt 5000000000 UNT/ML Topical Suspension [Vyjuvek] RxCUI 2637767

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Beremagene geperpavec 2637758
    • Beremagene geperpavec-svdt 2637757
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vyjuvek 2637763
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Beremagene geperpavec Topical Suspension 2637761
    • Beremagene geperpavec-svdt Topical Suspension 2648904
    • Beremagene geperpavec Topical Product 2637760
    • Beremagene geperpavec-svdt Topical Product 2660602
    • Beremagene geperpavec Topical Suspension [Vyjuvek] 2637766
    • Beremagene geperpavec-svdt Topical Suspension [Vyjuvek] 2658439
    • Vyjuvek Topical Product 2637765
    • Topical Suspension 1649353
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Beremagene geperpavec-svdt 5000000000 UNT/ML Topical Suspension SCD · 2637762
  • Beremagene geperpavec-svdt 5000000000 UNT/ML SCDC · 2637759
  • Beremagene geperpavec Topical Suspension SCDF · 2637761
  • Beremagene geperpavec-svdt Topical Suspension SCDFP · 2648904
  • Beremagene geperpavec Topical Product SCDG · 2637760
  • Beremagene geperpavec-svdt Topical Product SCDGP · 2660602

Brand-Name Concepts

  • Beremagene geperpavec-svdt 5000000000 UNT/ML [Vyjuvek] SBDC · 2637764
  • Beremagene geperpavec Topical Suspension [Vyjuvek] SBDF · 2637766
  • Beremagene geperpavec-svdt Topical Suspension [Vyjuvek] SBDFP · 2658439
  • Vyjuvek Topical Product SBDG · 2637765
  • Vyjuvek BN · 2637763

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2637767 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
82194-0510-02 1 KIT in 1 CARTON (82194-510-02) * 1 mL in 1 VIAL (82194-5... VYJUVEK Krystal Biotech, Inc. 2023-05-19
Observed labelers: Krystal Biotech, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J3401 Vyjuvek 5x10^9pfu/ml, 0.1 ml 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.